[ad_1] New Delhi: Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative approval granted by the US Food & Drug Administration (USFDA) is for its supplemental abbreviated new drug application (sANDA) Bosutinib tablets…
[ad_1] Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine. The approval by the US Food & Drug Administration (USFDA) is for the Abbreviated New Drug Application (ANDA) Sumatriptan Injection of strengths 4 mg/0.5 ml and…
[ad_1] Alembic Pharmaceuticals Ltd on Thursday said it has received a final approval from the US health regulator for its generic version of Paroxetine extended-release tablets indicated for treatment of depression and anxiety. The final approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Paroxetine extended-release…